Diagnostic accuracy of a novel point-of-care urine lipoarabinomannan assay for the detection of tuberculosis among adult outpatients in Zambia: a prospective cross-sectional study

被引:13
作者
Muyoyeta, Monde [1 ]
Kerkhoff, Andrew D. [2 ,3 ]
Chilukutu, Lophina [1 ]
Moreau, Emmanuel [4 ]
Schumacher, Samuel G. [4 ]
Ruhwald, Morten [4 ]
机构
[1] Ctr Infect Dis Res Zambia, Lusaka, Zambia
[2] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Div HIV Infect Dis & Global Med, San Francisco, CA 94117 USA
[3] Univ Calif San Francisco, Ctr Trauma, Div HIV Infect Dis & Global Med, San Francisco, CA 94117 USA
[4] Fdn Innovat New Diagnost FIND, Geneva, Switzerland
关键词
MYCOBACTERIUM-TUBERCULOSIS; XPERT MTB/RIF;
D O I
10.1183/13993003.03999-2020
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background A novel, rapid, point-of-care urine-based lipoarabinomannan assay (Fujifilm SILVAMP TB LAM ("FujiLAM")) has previously demonstrated substantially higher sensitivity for tuberculosis (TB) compared with the commercially available Determine TB LAM assay using biobanked specimens. However, FujiLAM has not been prospectively evaluated using fresh urine specimens. Therefore, we determined the diagnostic accuracy of FujiLAM among HIV-positive and HIV-negative outpatients with presumptive TB in Zambia. Methods Adult (> 18 years old) presumptive TB patients presenting to two outpatient public health facilities in Lusaka were included. All patients submitted sputa samples for smear microscopy, Xpert MTB/RIF and mycobacterial culture, and urine samples for the FujiLAM assay. Microbiologically confirmed TB was defined by the detection of Mycobacterium tuberculosis in sputum using culture; this served as the reference standard to assess the diagnostic accuracy of FujiLAM. Results 151 adults with paired sputum microbiological tests and urine FujiLAM results were included; 45% were HIV-positive. Overall, 34 out of 151 (23%) patients had culture-confirmed pulmonary TB. The overall sensitivity and specificity of FujiLAM was 77% (95% CI 59-89%) and 92% (95% CI 86-96%), respectively. FujiLAM's sensitivity among HIV-positive patients was 75% (95% CI 43-95%) compared with 75% (95% CI 51-91%) among HIV-negative patients. The sensitivity of FujiLAM in patients with smear-positive, confirmed pulmonary TB was 87% (95% CI 60-98%) compared with 68% (95% CI 43-87%) among patients with smear-negative, confirmed pulmonary TB. Conclusions FujiLAM demonstrated high sensitivity for the detection of TB among both HIV-positive and HIV-negative adults, and also demonstrated good specificity despite the lack of systematic extrapulmonary sampling to inform a comprehensive microbiological reference standard.
引用
收藏
页数:8
相关论文
共 16 条
[11]  
Kandhakumari G, 2017, INDIAN J PATHOL MICR, V60, P243, DOI [10.4103/IJPM.IJPM_695_15, 10.4103/ijpm.ijpm_695_15]
[12]   Diagnostic sensitivity of SILVAMP TB-LAM (FujiLAM) point-of-care urine assay for extra-pulmonary tuberculosis in people living with HIV [J].
Kerkhoff, Andrew D. ;
Sossen, Bianca ;
Schutz, Charlotte ;
Reipold, Elena Ivanova ;
Trollip, Andre ;
Moreau, Emmanuel ;
Schumacher, Samuel G. ;
Burton, Rosie ;
Ward, Amy ;
Nicol, Mark P. ;
Meintjes, Graeme ;
Denkinger, Claudia M. ;
Broger, Tobias .
EUROPEAN RESPIRATORY JOURNAL, 2020, 55 (02)
[13]  
Sigal GB, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/jcm.01338-18, 10.1128/JCM.01338-18]
[14]  
Singhroy Diane N, 2020, Gates Open Res, V4, P24, DOI 10.12688/gatesopenres.13112.2
[15]  
World Health Organization, 2019, Lateral flow urine lipoarabinomannan assay (LF- LAM) for the diagnosis of active tuberculosis in people living with HIV, 2019 update
[16]  
World Health Organization, 2014, HIGH PRIOR TARG PROD